SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, is scheduled to present and host investor meetings at the following investor conferences:
Read more at prnewswire.com
Halozyme to Participate in Upcoming Investor Conferences
Provided By PR Newswire – Last update: